Zenas BioPharma

Featured

4 Stocks Leading the Charge in the $20 Billion Race to Stop the Progression of Multiple Sclerosis

December 16, 2024
0
Human brain, with electrical flashes from Multiple Sclerosis on a blue background.

The multiple sclerosis (MS) treatment market, valued at over $20 billion annually, is experiencing a transformative phase. With no definitive…

Read More »
Back to top button